ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Developing An Effective Lipid Nanoparticle Formulation Process For Small Molecule And Biologicals Delivery

  Lipid nanoparticles (LNPs) are a versatile formulation technology used by drug development teams to deliver a variety of small/large molecules, peptides, and biologicals.

• Off-The-Shelf Vs. Novel Devices: Selecting A Drug Delivery System

  Whether bringing a novel therapy to market or altering current devices, companies must determine the best selection for administration without impacting drug efficacy, quality, and safety.

• Layer By Layer: 3D Screen Printing And The Future Of Drug Development

  3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.

• Reducing Lead Time & Optimizing Costs

  Explore how the use of this component platform produces significant savings, reduces elastomer SKU complexity, and increases speed to market.

• The Importance Of Strategic Alliance Partners In Biopharmaceuticals

  Today’s drug delivery systems are complex technologies that require close teamwork between biopharmaceutical companies and their drug delivery technology partners to develop innovative platforms.

• New Polymer Overcomes Limits In Sustained Drug Delivery In Ophthalmology

  Challenges specific to eye physiology complicate the development of new therapies and necessitate innovative drug delivery methods. Biodegradable polymers show promise in addressing these challenges.

• Selecting An Alternative Coating Technology To Silicone Oil For Prefillable Syringes

  The challenges of silicone-oil lubrication and the growing trend for more viscous, protein-based drugs are now leading pharma and biotech companies to investigate alternative solutions.

• Evolution Of Novel Polymers To Overcome Limits In Sustained Drug Delivery

  Degradable polymers evolved from aliphatic polyesters to nitrogen-bearing biomaterials such as polyurethanes and polyester amides. Explore a brief history of the development of PEA polymers.

• Improve Speed To Market By Mitigating Vial And Stopper Incompatibility

  These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.

• Maximize Global Regulatory Collaboration

  When marketing a combination product globally, pharmaceutical manufacturers and drug delivery technology providers must have a collaborative infrastructure based on strategic alignment, proactive regulatory awareness, lifecycle support, and continuous improvement globally.